Unknown

Dataset Information

0

Defining quantification methods and optimizing protocols for microarray hybridization of circulating microRNAs.


ABSTRACT: MicroRNAs (miRNAs) have emerged as promising biomarkers of disease. Their potential use in clinical practice requires standardized protocols with very low miRNA concentrations, particularly in plasma samples. Here we tested the most appropriate method for miRNA quantification and validated the performance of a hybridization platform using lower amounts of starting RNA. miRNAs isolated from human plasma and from a reference sample were quantified using four platforms and profiled with hybridization arrays and RNA sequencing (RNA-seq). Our results indicate that the Infinite® 200 PRO Nanoquant and Nanodrop 2000 spectrophotometers magnified the miRNA concentration by detecting contaminants, proteins, and other forms of RNA. The Agilent 2100 Bioanalyzer PicoChip and SmallChip gave valuable information on RNA profile but were not a reliable quantification method for plasma samples. The Qubit® 2.0 Fluorometer provided the most accurate quantification of miRNA content, although RNA-seq confirmed that only ~58% of small RNAs in plasma are true miRNAs. On the other hand, reducing the starting RNA to 70% of the recommended amount for miRNA profiling with arrays yielded results comparable to those obtained with the full amount, whereas a 50% reduction did not. These findings provide important clues for miRNA determination in human plasma samples.

SUBMITTER: Garcia-Elias A 

PROVIDER: S-EPMC5552704 | biostudies-literature | 2017 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Defining quantification methods and optimizing protocols for microarray hybridization of circulating microRNAs.

Garcia-Elias Anna A   Alloza Leonor L   Puigdecanet Eulàlia E   Nonell Lara L   Tajes Marta M   Curado Joao J   Enjuanes Cristina C   Díaz Oscar O   Bruguera Jordi J   Martí-Almor Julio J   Comín-Colet Josep J   Benito Begoña B  

Scientific reports 20170810 1


MicroRNAs (miRNAs) have emerged as promising biomarkers of disease. Their potential use in clinical practice requires standardized protocols with very low miRNA concentrations, particularly in plasma samples. Here we tested the most appropriate method for miRNA quantification and validated the performance of a hybridization platform using lower amounts of starting RNA. miRNAs isolated from human plasma and from a reference sample were quantified using four platforms and profiled with hybridizati  ...[more]

Similar Datasets

| S-EPMC3948704 | biostudies-literature
| S-EPMC4687703 | biostudies-other
| S-EPMC5438360 | biostudies-literature
| S-EPMC4380332 | biostudies-literature
| S-EPMC2395252 | biostudies-literature
| S-EPMC7443869 | biostudies-literature
| S-EPMC4238961 | biostudies-literature
| S-EPMC3430688 | biostudies-literature
| S-EPMC5183575 | biostudies-literature
| S-EPMC3866270 | biostudies-literature